The Ad Council launched today a new version of their digital distribution platform, PSA Central, making it the first single source destination for all Ad Council PSAs. The platform provides easy access to broadcast-quality television spots in multiple HD and SD formats, as well as ads created for radio, print, online, mobile and outdoor media.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61747-ad-council-launches-first-high-res-psa-distribution-platform
VISTAKON® Division of Johnson & Johnson Vision Care, Inc., and the makers of ACUVUE® Brand Contact Lenses, today revealed the 2012 celebrity ensemble for this year’s “ACUVUE® 1-DAYContest.” The roster of celebrity mentors includes inspirational pop star Demi Lovato, musician Joe Jonas, breakout television star Tyler Blackburn, all-American actress Meaghan Martin and world champion sprinter Allyson Felix. The contest, now in its second year, will give five winners the chance to meet and be mentored for a day by one of the five teen icons.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55568-acuvue-brand-contact-lenses-launches-the-2012-acuvue-1-day-contest
Today, Absolut Vodka® celebrates its latest global campaign – Create a Better Tomorrow, Tonight – with the launch of The Open Mic Project. This collaborative initiative, designed in partnership with singer songwriter and actress Rita Ora, provides a platform for amplifying, and uniting, voices across the nation to refresh the talk. As a brand known for collaborating with creative forces big and small – from artists to musicians to mixologists – The Open Mic Project aligns to Absolut’s larger mission of using creativity as a force for positive change and inspiring action.
For nearly 40 years, Absolut has used nightlife, quality cocktails and creative collaborations to break down traditional barriers and forge unique connections. Now, with The Open Mic Project, Absolut is fusing these platforms together to spark a much-needed change in today’s conversation, by giving all people – regardless of background, belief or border – a voice.
To view the multimedia release go to:
https://www.multivu.com/players/English/8197551-absolut-vodka-launches-the-open-mic-project/
Forty-five million people – or 1 in 7 Americans – are living in poverty in the United States today. It often takes just one misfortune or one missed paycheck to change an individual or family’s life causing them to fall below the poverty line. Today, Catholic Charities USA (CCUSA) launches #End45 – Raise a Hand to End Poverty in America, a national initiative to help shine a spotlight on the issue and the millions of others in need or struggling to make ends meet.
Timed to coincide with Pope Francis’s visit to the United States in late September and to align with his commitment to helping the poor, #End45 – Raise a Hand to End Poverty in America encourages individuals to show support for the cause by taking a picture of their hand with “#End45” written on the palm and posting it to their social media channels using the hashtag #End45.
To view the multimedia release go to:
http://www.multivu.com/players/English/7599151-catholic-charities-end-poverty-in-america/
AbbVie (NYSE:ABBV) today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange.
With a rich, 125-year heritage of developing pharmaceuticals, AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. A global enterprise that serves patients in more than 170 countries, AbbVie launches with an estimated $18 billion in annual revenues and a strong commitment to creating shareholder value through long-term growth potential and the continuation of the company’s history of shareholder dividends.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59757-abbvie-celebrates-launch-as-new-biopharmaceutical-company
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions.
“We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
The RCS Engineers Rocketry Team from Russellville, Ala., beat out 100 competitors to claim first place at the National Finals of the 2015 Team America Rocketry Challenge (TARC). After months of rocketry design, test flights and qualification launches, hundreds of students from across the country traveled to Great Meadow in the Plains, Va., to vie for the title of champion of the largest rocketry competition in the world.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7427051-team-america-rocketry-challenge/
Generations of the Lexus LS have inspired an entire industry through visionary innovation, craftsmanship and design. And now the flagship not only has a new face, but has more than 3,000 new parts. The LS line-up also includes the first-ever LS F SPORT, and a marketing campaign to highlight the thrilling, exclusive lifestyle LS drivers live. The LS campaign caps off a successful year of launches showcasing the brand’s bold new face and attitude for the future.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58825-lexus-ls-2013-marketing-campaign
The ATP this week launches a new global promotional campaign as the 2013 ATP World Tour season begins with tournaments in Chennai, Doha and Brisbane. The campaign, which uses the tagline “BEAT THIS”, showcases the world-class entertainment and drama produced by the world’s finest athletes on the greatest stages across the ATP World Tour.
The multi-million dollar campaign features established global stars such as Novak Djokovic, Roger Federer, Andy Murray and Rafael Nadal, as well as the next generation, including the likes of Milos Raonic and Kei Nishikori.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58667-ATP-world-tour-global-promotional-campaign
Global superstar and Grammy award winner Enrique Iglesias will perform LIVE for The Salvation Army’s 15th annual Red Kettle Kickoff during halftime of the Dallas Cowboys Thanksgiving Day game against the Miami Dolphins at 3:15 CST on the CBS television network. The nationally televised performance launches The Salvation Army’s 120th annual Red Kettle Campaign, which began on the wharf in San Francisco in 1891 and has spread worldwide to raise money for people in need. Last year, the campaign recorded a record $142 million, mostly in small denomination donations from holiday shoppers. This year, the nation’s oldest and longest running fundraiser will continue to expand its partnerships and use of technology to give donors and volunteers more ways to help others.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52629-salvation-army-s-red-kettle-campaign-120th-anniversary-dallas-cowboys
Today, Johnson & Johnson, the world’s largest healthcare company, launches Johnson & Johnson Our Story at the Powerhouse and Johnson & Johnson Our Story to take visitors on a journey through time and around the world as they explore the stories behind more than 130 years of innovations that have changed the course of human health.
To view the multimedia release go to:
https://www.multivu.com/players/English/8077331-jnj-our-story/